Stockreport

Pfizer Reshapes Portfolio With Obesity Bet, Vaccine Deal And Pricing Shift [Yahoo! Finance]

Novavax, Inc.  (NVAX) 
Last novavax, inc. earnings: 3/11 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novavax.com/investor-relations
PDF Pfizer (NYSE:PFE) agreed to acquire weight loss drug developer Metsera for US$10b, entering the obesity and GLP-1 market. The company signed a licensing deal with Nov [Read more]